Literature DB >> 24220876

The association between serum Dickkopf-1 levels and esophageal squamous cell carcinoma.

H Begenik1, A S Kemik2, H Emre3, A C Dulger4, D Demirkiran3, S Ebinc3, O Kemik5.   

Abstract

Serum Dickkopf-1(DKK-1) is elevated in many malignancies and is an important indicator of malignant potential. However, its significance in esophageal squamous cell cancer (ESCC) has not yet been clarified. We hypothesized a role for DKK-1 in patients with ESCC. The study consisted of 90 ESCC patients and 85 healthy controls. After diagnosis, the level of DKK-1 was measured in the serum samples by enzyme-linked immunosorbent assay and the levels of DKK-1 were much higher in the ESCC patients than in the healthy control group (p < 0.0001). For serum DKK-1, the sensitivity and specificity of the assay were 70 and 80%, respectively. The preoperative serum DKK-1 level was elevated in the ESCC patients. Although serum DKK-1 is not a specific biomarker for ESCC, it might be a useful marker for the diagnosis and treatment of ESCC.
© The Author(s) 2014.

Entities:  

Keywords:  Dickkopf-1; Esophageal squamous cell cancer

Mesh:

Substances:

Year:  2013        PMID: 24220876     DOI: 10.1177/0960327113510537

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  7 in total

Review 1.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

Review 2.  The role of Dickkopf family in cancers: from Bench to Bedside.

Authors:  You-Cheng Shao; Yan Wei; Jin-Fang Liu; Xiao-Yan Xu
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

3.  Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.

Authors:  Yu-Hui Peng; Yi-Wei Xu; Hong Guo; Li-Sheng Huang; Hua-Zhen Tan; Chao-Qun Hong; Shan-Shan Li; Li-Yan Xu; En-Min Li
Journal:  Cancer Med       Date:  2016-03-14       Impact factor: 4.452

Review 4.  Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Authors:  Michael H Kagey; Xi He
Journal:  Br J Pharmacol       Date:  2017-07-07       Impact factor: 8.739

5.  Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma.

Authors:  Mona Kamal Eldeeb; Gehan Mahmoud Magour; Rania Nabil Bedair; Mohammed Mahmoud Shamseya; Mennatallah Abdelfattah Hammouda
Journal:  Clin Exp Hepatol       Date:  2020-05-29

Review 6.  Drug Discovery of DKK1 Inhibitors.

Authors:  Hewen Jiang; Zongkang Zhang; Yuanyuan Yu; Hang Yin Chu; Sifan Yu; Shanshan Yao; Ge Zhang; Bao-Ting Zhang
Journal:  Front Pharmacol       Date:  2022-03-09       Impact factor: 5.810

Review 7.  Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?

Authors:  Mélody Mazon; Delphine Masi; Madeleine Carreau
Journal:  Cancers (Basel)       Date:  2016-06-28       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.